Microglia and schizophrenia: where next?

Saved in:
Bibliographic Details
Published in:Molecular psychiatry 2017-06, Vol.22 (6), p.788-789
Main Authors: Notter, T, Meyer, U
Format: Article
Language:English
Subjects:
631/378
692/699/476/1799
Animals
Antipsychotics
Behavioral Sciences
Biological Psychology
Brain research
Development and progression
Diagnosis
Disease Models, Animal
Health aspects
Hypotheses
Ligands
Medicine
Medicine & Public Health
Membrane proteins
Mental disorders
Microglia
Neurosciences
news-and-commentary
PET imaging
Pharmacotherapy
Physiological aspects
Properties
Protein binding
Psychiatric research
Psychiatry
Psychosis
Psychotropic drugs
Schizophrenia
Toxicology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3
cites cdi_FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3
container_end_page 789
container_issue 6
container_start_page 788
container_title Molecular psychiatry
container_volume 22
creator Notter, T
Meyer, U
description
doi_str_mv 10.1038/mp.2017.67
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2615532095</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689285326</galeid><sourcerecordid>A689285326</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3</originalsourceid><addsrcrecordid>eNqNkUlLQzEUhYMozht_gBTciPJqbua4EREnUNzoOqR5eW2kbzBpcfj1plSloohkkXDvd84N9yC0A7gPmKqjuusTDLIv5BJaByZFwblUy_lNuS4YKLaGNlJ6xHjW5KtojSjKFFVsHe3fBhfb4TjYnm3KXnKj8NZ2o-ibYI97zyMffa_xL5OTLbRS2XHy2x_3Jnq4OL8_uypu7i6vz05vCseIkgVjrmQDroFLDVjyikoQihKv9EBK6weW5j8LrqjzmmgHVCrAWQRQYYZLuon25r5dbJ-mPk3MYzuNTR5piADOKcGa_0WBxlhqCrBADe3Ym9BU7SRaV4fkzKlQmqjsJv6kmCaMCSlYpvq_UPmUvg6ubXwVcv2b7b8EixMO5oIcSErRV6aLobbx1QA2s6BN3ZlZ0EbIDO9-LGA6qH35hX4mm4HDOZByqxn6uLChn3bvyeyptg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1900793115</pqid></control><display><type>article</type><title>Microglia and schizophrenia: where next?</title><source>Springer Link</source><creator>Notter, T ; Meyer, U</creator><creatorcontrib>Notter, T ; Meyer, U</creatorcontrib><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/mp.2017.67</identifier><identifier>PMID: 28348384</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/378 ; 692/699/476/1799 ; Animals ; Antipsychotics ; Behavioral Sciences ; Biological Psychology ; Brain research ; Development and progression ; Diagnosis ; Disease Models, Animal ; Health aspects ; Hypotheses ; Ligands ; Medicine ; Medicine &amp; Public Health ; Membrane proteins ; Mental disorders ; Microglia ; Neurosciences ; news-and-commentary ; PET imaging ; Pharmacotherapy ; Physiological aspects ; Properties ; Protein binding ; Psychiatric research ; Psychiatry ; Psychosis ; Psychotropic drugs ; Schizophrenia ; Toxicology</subject><ispartof>Molecular psychiatry, 2017-06, Vol.22 (6), p.788-789</ispartof><rights>Macmillan Publishers Limited, part of Springer Nature. 2017</rights><rights>COPYRIGHT 2017 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jun 2017</rights><rights>Macmillan Publishers Limited, part of Springer Nature. 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3</citedby><cites>FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28348384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Notter, T</creatorcontrib><creatorcontrib>Meyer, U</creatorcontrib><title>Microglia and schizophrenia: where next?</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><subject>631/378</subject><subject>692/699/476/1799</subject><subject>Animals</subject><subject>Antipsychotics</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Brain research</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Disease Models, Animal</subject><subject>Health aspects</subject><subject>Hypotheses</subject><subject>Ligands</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Membrane proteins</subject><subject>Mental disorders</subject><subject>Microglia</subject><subject>Neurosciences</subject><subject>news-and-commentary</subject><subject>PET imaging</subject><subject>Pharmacotherapy</subject><subject>Physiological aspects</subject><subject>Properties</subject><subject>Protein binding</subject><subject>Psychiatric research</subject><subject>Psychiatry</subject><subject>Psychosis</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><subject>Toxicology</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkUlLQzEUhYMozht_gBTciPJqbua4EREnUNzoOqR5eW2kbzBpcfj1plSloohkkXDvd84N9yC0A7gPmKqjuusTDLIv5BJaByZFwblUy_lNuS4YKLaGNlJ6xHjW5KtojSjKFFVsHe3fBhfb4TjYnm3KXnKj8NZ2o-ibYI97zyMffa_xL5OTLbRS2XHy2x_3Jnq4OL8_uypu7i6vz05vCseIkgVjrmQDroFLDVjyikoQihKv9EBK6weW5j8LrqjzmmgHVCrAWQRQYYZLuon25r5dbJ-mPk3MYzuNTR5piADOKcGa_0WBxlhqCrBADe3Ym9BU7SRaV4fkzKlQmqjsJv6kmCaMCSlYpvq_UPmUvg6ubXwVcv2b7b8EixMO5oIcSErRV6aLobbx1QA2s6BN3ZlZ0EbIDO9-LGA6qH35hX4mm4HDOZByqxn6uLChn3bvyeyptg</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Notter, T</creator><creator>Meyer, U</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20170601</creationdate><title>Microglia and schizophrenia: where next?</title><author>Notter, T ; Meyer, U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>631/378</topic><topic>692/699/476/1799</topic><topic>Animals</topic><topic>Antipsychotics</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Brain research</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Disease Models, Animal</topic><topic>Health aspects</topic><topic>Hypotheses</topic><topic>Ligands</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Membrane proteins</topic><topic>Mental disorders</topic><topic>Microglia</topic><topic>Neurosciences</topic><topic>news-and-commentary</topic><topic>PET imaging</topic><topic>Pharmacotherapy</topic><topic>Physiological aspects</topic><topic>Properties</topic><topic>Protein binding</topic><topic>Psychiatric research</topic><topic>Psychiatry</topic><topic>Psychosis</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Notter, T</creatorcontrib><creatorcontrib>Meyer, U</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Notter, T</au><au>Meyer, U</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microglia and schizophrenia: where next?</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>22</volume><issue>6</issue><spage>788</spage><epage>789</epage><pages>788-789</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28348384</pmid><doi>10.1038/mp.2017.67</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-4184
ispartof Molecular psychiatry, 2017-06, Vol.22 (6), p.788-789
issn 1359-4184
1476-5578
language eng
recordid cdi_proquest_journals_2615532095
source Springer Link
subjects 631/378
692/699/476/1799
Animals
Antipsychotics
Behavioral Sciences
Biological Psychology
Brain research
Development and progression
Diagnosis
Disease Models, Animal
Health aspects
Hypotheses
Ligands
Medicine
Medicine & Public Health
Membrane proteins
Mental disorders
Microglia
Neurosciences
news-and-commentary
PET imaging
Pharmacotherapy
Physiological aspects
Properties
Protein binding
Psychiatric research
Psychiatry
Psychosis
Psychotropic drugs
Schizophrenia
Toxicology
title Microglia and schizophrenia: where next?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A50%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microglia%20and%20schizophrenia:%20where%20next?&rft.jtitle=Molecular%20psychiatry&rft.au=Notter,%20T&rft.date=2017-06-01&rft.volume=22&rft.issue=6&rft.spage=788&rft.epage=789&rft.pages=788-789&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/mp.2017.67&rft_dat=%3Cgale_proqu%3EA689285326%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4287-44cd4b5915791075f3716832e89b77aeba31036583ce929c1378104cd11f040d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1900793115&rft_id=info:pmid/28348384&rft_galeid=A689285326&rfr_iscdi=true